MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

OBJECTIVE: Tau hyperphosphorylation at threonine 217 (pT217) in cerebrospinal fluid (CSF) has recently been linked to early amyloidosis and could serve as a highly sensitive biomarker for Alzheimer’s disease (AD). However, it remains unclear whether other tauopathies induce pT217 modifications. To d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Chihiro, Mallipeddi, Nipun, Ghoshal, Nupur, Wright, Brenton A., Day, Gregory S., Davis, Albert A., Kim, Albert H., Zipfel, Gregory J., Bateman, Randall J., Gabelle, Audrey, Barthélemy, Nicolas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419397/
https://www.ncbi.nlm.nih.gov/pubmed/34342183
http://dx.doi.org/10.1002/acn3.51435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419397/
https://www.ncbi.nlm.nih.gov/pubmed/34342183
http://dx.doi.org/10.1002/acn3.51435

Ejemplares similares